Serologic response to human papillomavirus type 16 virus-like particles in Korean women with cervical precancerous and cancerous lesions

Archives of Pharmacal Research

Volumn 32, Issue 3, 2009, Pages 383-389

  Jeong, Nan Hee ^a   Lee, Nak Woo ^b   Woo, Mi Kyung ^c   Kim, Hong Jin ^c  

^a Kyung Hee University Hospital   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Chung Ang University   (South Korea)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; Enzyme linked immunosorbent assay; Human papillomavirus; Serology; Virus like particles

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER PATIENT; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRECANCER; SEROLOGY; SEROPREVALENCE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS PARTICLE;

ADULT; AGE FACTORS; AGED; ANTIBODIES, VIRAL; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; KOREA; LOGISTIC MODELS; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; UTERINE CERVICAL NEOPLASMS; VIRION; YOUNG ADULT;

EID: 65449177715     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-1311-1     Document Type: Article

References (27)

1. Bosch, F. X. and De Sanjose, S., Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr, 3-13 (2003).
2. J. J. Carter L. A. Koutsky J. P. Hughes S. K. Lee J. Kuypers N. Kiviat D. A. Galloway 2000 Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection J Infect Dis 181 1911 1919
3. J. J. Carter L. A. Koutsky G. C. Wipf N. D. Christensen S. K. Lee J. Kuypers N. Kiviat D. A. Galloway 1996 The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women J Infect Dis 174 927 936
4. H. H. Chung M. J. Jang K. W. Jung Y. J. Won H. R. Shin J. W. Kim H. P. Lee 2006 Cervical cancer incidence and survival in Korea: 1993-2002 Int J Gynecol Cancer 16 1833 1838
5. G. M. Clifford H. R. Shin J. K. Oh T. Waterboer Y. H. Ju S. Vaccarella W. Quint M. Pawlita S. Franceschi 2007 Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea Cancer Epidemiol Biomarkers Prev 16 1874 1879
6. A. L. Combita M. M. Bravo A. Touze O. Orozco P. Coursaget 2002 Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 viruslike particles in colombian women with invasive cervical cancer Int J Cancer 97 796 803
7. T. D. De Gruijl H. J. Bontkes J. M. Walboomers J. T. Schiller M. J. Stukart B. S. Groot M. M. Chabaud A. J. Remmink R. H. Verheijen T. J. Helmerhorst C. J. Meijer R. J. Scheper 1997 Immunoglobulin G responses against human papillomavirus type 16 viruslike particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia J Natl Cancer Inst 89 630 638
8. J. Dillner 1999 The serological response to papillomaviruses Semin Cancer Biol 9 423 430
9. E. F. Dunne K. L. Karem M. R. Sternberg K. M. Stone E. R. Unger W. C. Reeves L. E. Markowitz 2005 Seroprevalence of human papillomavirus type 16 in children J Infect Dis 191 1817 1819
10. M. H. Einstein Y. Y. Studentsov G. Y. Ho M. Fazzari M. Marks A. S. Kadish G. L. Goldberg C. D. Runowicz R. D. Burk 2007 Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia Int J Cancer 120 55 59
11. K. Heim A. Widschwendter H. Szedenik A. Geier N. D. Christensen A. Bergant N. Concin R. Hopfl 2005 Specific serologic response to genital human papillomavirus types in patients with vulvar precancerous and cancerous lesions Am J Obstet Gynecol 192 1073 1083
12. G. Y. Ho R. Bierman L. Beardsley C. J. Chang R. D. Burk 1998 Natural history of cervicovaginal papillomavirus infection in young women N Engl J Med 338 423 428
13. G. Y. Ho Y. Studentsov C. B. Hall R. Bierman L. Beardsley M. Lempa R. D. Burk 2002 Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 viruslike particles J Infect Dis 186 737 742
14. W. D. Joo W. D. Joo S. H. Kim S. H. Kim D. Y. Kim D. Y. Kim D. S. Suh D. S. Suh J. H. Kim J. H. Kim Y. M. Kim Y. M. Kim Y. T. Kim Y. T. Kim J. E. Mok J. E. Mok J. H. Nam J. H. Nam 2004 Prevalence of human papillomavirus infection in Korean women: Risks of abnormal pap smear and cervical neoplasia Korean J Gynecol Oncol Colposc 15 309 316
15. H. J. Kim M. A. Park H. J. Kim 2008 Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae Protein Expr. Purif. 59 175 181
16. S. N. Kim H. S. Jeong S. N. Park H. J. Kim 2007 Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae J Virol Methods 139 24 30
17. R. Kirnbauer N. L. Hubbert C. M. Wheeler T. M. Becker D. R. Lowy J. T. Schiller 1994 A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16 J Natl Cancer Inst 86 494 499
18. P. Le Cann A. Touze N. Enogat D. Leboulleux C. Mougin M. C. Legrand C. Calvet J. M. Afoutou P. Coursaget 1995 Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus J Clin Microbiol 33 1380 1382
19. N. Munoz 2003 Value of human papilloma virus testing in the diagnosis and screening of cervical neoplasia Med Clin (Barc) 121 455 456
20. J. S. Park E. S. Hwang H. K. Ahn C. J. Kim G. T. Jung H. S. Kim S. H. Park S. E. Namkoong S. J. Kim 1996 Seroreactivities to HPV-16 Virus Like Particles (VLPs) using ELISA in the patients with cervical neoplasia Korean J Obstet Gynecol 39 176 185
21. J. S. Park D. C. Park C. J. Kim H. K. Ahn S. J. Um S. N. Park S. J. Kim S. E. Namkoong 1998 HPV-16-related proteins as the serologic markers in cervical neoplasia Gynecol Oncol 69 47 55
22. L. Pirami V. Giache A. Becciolini 1997 Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix J Clin Pathol 50 600 604
23. T. Sasagawa H. Yamazaki Y. Z. Dong S. Satake M. Tateno M. Inoue 1998 Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions Int J Cancer 75 529 535
24. M. H. Schiffman H. M. Bauer R. N. Hoover A. G. Glass D. M. Cadell B. B. Rush D. R. Scott M. E. Sherman R. J. Kurman S. Wacholder 1993 Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia J Natl Cancer Inst 85 958 964
25. D. Skiba G. Mehlhorn P. A. Fasching M. W. Beckmann S. Ackermann 2006 Prognostic significance of serum antibodies to HPV-16 L1 virus-like particles in patients with invasive cervical cancer Anticancer Res 26 4921 4926
26. K. M. Stone K. L. Karem M. R. Sternberg G. M. Mcquillan A. D. Poon E. R. Unger W. C. Reeves 2002 Seroprevalence of human papillomavirus type 16 infection in the United States J Infect Dis 186 1396 1402
27. L. Wideroff M. Schiffman P. Haderer A. Armstrong C. E. Greer M. M. Manos R. D. Burk D. R. Scott M. E. Sherman J. T. Schiller R. N. Hoover R. E. Tarone R. Kirnbauer 1999 Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions J Infect Dis 180 1424 1428